Reported about 14 hours ago
Tylenol manufacturer Kenvue Inc. faces a serious crisis following President Trump's cautionary remarks about its product, suggesting pregnant women shouldn't use Tylenol due to unproven links to autism. This comment revives potential litigation risks for Kenvue, especially if the FDA enforces a label warning regarding autism risks, potentially leading to renewed lawsuits that the company thought were behind them. Amidst these challenges, Kenvue struggles with declining sales and investor pressures, marking a troubling period for the company.
Source: YAHOO